MARKET

QGEN

QGEN

Qiagen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

43.67
-0.12
-0.27%
Pre Market: 44.01 +0.34 +0.78% 08:15 06/02 EDT
OPEN
43.50
PREV CLOSE
43.79
HIGH
43.77
LOW
43.46
VOLUME
697.57K
TURNOVER
--
52 WEEK HIGH
43.94
52 WEEK LOW
25.04
MARKET CAP
9.96B
P/E (TTM)
-294.8683
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average QGEN stock price target is 38.40 with a high estimate of 43.00 and a low estimate of 31.00.

EPS

QGEN News

More
QIAGEN Sales Grow on Coronavirus Solutions Ahead of Selloff
Zacks · 21h ago
Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio
Zacks · 21h ago
How QIAGEN (QGEN) Stock Stands Out in a Strong Industry?
Zacks · 3d ago
Stocks That Hit 52-Week Highs On Friday
On Friday morning, 45 companies hit new 52-week highs.
Benzinga · 3d ago
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28)
Benzinga · 4d ago
QIAGEN Builds on Leading Position in Precision Medicine With Novel Solutions in Oncology
Business Wire · 4d ago
QGEN vs. RGEN: Which Stock Is the Better Value Option?
Zacks · 4d ago
Zacks.com featured highlights include: SpartanNash Company, BG Foods, QIAGEN, Regeneron Pharmaceuticals and United Therapeutics
Zacks · 4d ago

Industry

Biotechnology & Medical Research
+0.07%
Pharmaceuticals & Medical Research
-0.77%

Hot Stocks

Symbol
Price
%Change

About QGEN

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
More

Webull offers kinds of Qiagen NV stock information, including NASDAQ:QGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QGEN stock news, and many more online research tools to help you make informed decisions.